Pharmaceutical News

RSS

Researchers develop model that predicts changes in BUP exposure during pregnancy

Buprenorphine (BUP) is approved for the treatment of opioid addiction. The current dosing regimen of BUP in pregnant women is based on recommendations designed for non-pregnant adults, but physiological changes during pregnancy may alter BUP exposure and efficacy.

7 Jun 2018

Fluence Analytics announces distribution agreement with Nihon Rufuto in Japan

Fluence Analytics, a manufacturer of industrial and laboratory analytics products, today announced it has signed a distribution agreement with Nihon Rufuto, a Japanese company specializing in the import and domestic sales of scientific instruments.

From Yokogawa Fluence Analytics 7 Jun 2018

Study finds high insurance denial rates for life-saving hepatitis C drugs in the U.S.

The number of insurance denials for life-saving hepatitis C drugs among patients with both private and public insurers remains high across the United States, researchers from the Perelman School of Medicine at the University of Pennsylvania reported in a new study published in the journal Open Forum Infectious Diseases.

7 Jun 2018

Two-drug combination provides more reliable, effective care for women suffering miscarriage

A combination of the drugs mifepristone and misoprostol can help bring closure to some women and their families suffering from miscarriage, and reduces the need for surgical intervention to complete the painful miscarriage process.

7 Jun 2018

Researchers’ attempt to combine immunotherapy drugs have turned out to be failure

A class of immunotherapy drugs called checkpoint inhibitors has shown great promise against cancer in some patients.

7 Jun 2018

FDA files complaint against company marketing unapproved hand sanitizers

The U.S. Food and Drug Administration today filed a complaint against Innovative BioDefense, Inc. of Lake Forest, California, and Colette Cozean, the company's president and chief executive officer, to prohibit them from selling Zylast topical antiseptics with claims that they are effective against infection by pathogens such as norovirus, rotavirus, flu virus, Methicillin-Resistant Staphylococcus Aureus, and Ebola.

7 Jun 2018

Relying on arthritis therapies alone may not improve patients' mental health, shows study

Drugs used to treat rheumatoid arthritis may impact mental health by improving pain and stiffness and by targeting inflammatory processes common to arthritis and depression; however, a recent review of published studies demonstrates that relying on rheumatoid arthritis therapies alone may not meaningfully improve patients' mental health.

6 Jun 2018

Price check on drug ads: Would revealing costs help patients control spending?

President Donald Trump wants to control spending on drugs. One of his big ideas: include prices in advertisements, just like warnings about side effects.

6 Jun 2018

FDA warns nine online networks to stop illegal marketing of unapproved opioids

The U.S. Food and Drug Administration today announced that it has warned nine online networks, operating a total of 53 websites, that they must stop illegally marketing potentially dangerous, unapproved and misbranded versions of opioid medications, including tramadol and oxycodone.

6 Jun 2018

Opioid misuse may compromise effectiveness of treatments for alcohol use disorder

New research indicates that opioid misuse and the use of cannabis and other drugs may compromise the effectiveness of treatments for alcohol use disorder.

6 Jun 2018

Study finds combination therapy to be safe, effective for treatment of male infertility

Two drugs that are commonly used off-label in the treatment of male infertility are clomiphene citrate (CC) and anastrozole (AZ); however, data are lacking on the use of combination CC+AZ therapy.

6 Jun 2018

Experimental drug shows potential to improve bladder function after spinal cord injury

An experimental drug that blocks abnormal neural communication after spinal cord injury could one day be the key to improving quality of life by improving bladder function, new research suggests.

5 Jun 2018

FDA approves first Neulasta biosimilar to help decrease infection risk during cancer treatment

The U.S. Food and Drug Administration today approved Fulphila (pegfilgrastim-jmdb) as the first biosimilar to Neulasta (pegfilgrastim) to decrease the chance of infection as suggested by febrile neutropenia (fever, often with other signs of infection, associated with an abnormally low number of infection-fighting white blood cells), in patients with non-myeloid (non-bone marrow) cancer who are receiving myelosuppressive chemotherapy that has a clinically significant incidence of febrile neutropenia.

4 Jun 2018

Diuretic drug may be just as effective as oral antibiotics to treat acne in female patients

In a finding that suggests the potential for practice change that would reduce the use of antibiotics in dermatology, researchers in the Perelman School of Medicine at the University of Pennsylvania have found the diuretic drug spironolactone may be just as effective as antibiotics for the treatment of women's acne.

4 Jun 2018

ORNL increases production of actinium-227 to meet demand for cancer drug

The Department of Energy's Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.

1 Jun 2018

Mistaken belief that antibiotics are harmless is widespread, finds study

A new study of decision-making about the use of antibiotics in medicine has found that the mistaken belief that antibiotics are harmless is widespread, especially among patients.

1 Jun 2018

Study: People taking immunosuppressant drugs less likely to develop Parkinson's disease

People who take drugs that suppress the immune system are less likely to develop Parkinson's disease, according to a study from Washington University School of Medicine in St. Louis.

31 May 2018

New system for anti-cancer drug delivery offers hope to treat pediatric tumors

In most of the Western World, cancer is the primary cause of death in children over the age of one. Existing treatments for adult cancer patients are not particularly effective for children.

31 May 2018

Cloud Pharmaceuticals enters into drug discovery collaboration with GSK

Cloud Pharmaceuticals, Inc., an Artificial Intelligence-driven drug design and development company, announced today they have entered into drug discovery collaboration with GlaxoSmithKline (GSK). Cloud will design novel small-molecule agents to GSK specified targets.

31 May 2018

FDA approves first oral medication for adults with moderately to severely active ulcerative colitis

The U.S. Food and Drug Administration today expanded the approval of Xeljanz (tofacitinib) to include adults with moderately to severely active ulcerative colitis. Xeljanz is the first oral medication approved for chronic use in this indication.

30 May 2018

Pharmaceutical News

Researchers develop model that predicts changes in BUP exposure during pregnancy

Fluence Analytics announces distribution agreement with Nihon Rufuto in Japan

Study finds high insurance denial rates for life-saving hepatitis C drugs in the U.S.

Two-drug combination provides more reliable, effective care for women suffering miscarriage

Researchers’ attempt to combine immunotherapy drugs have turned out to be failure

FDA files complaint against company marketing unapproved hand sanitizers

Relying on arthritis therapies alone may not improve patients' mental health, shows study

Price check on drug ads: Would revealing costs help patients control spending?

FDA warns nine online networks to stop illegal marketing of unapproved opioids

Opioid misuse may compromise effectiveness of treatments for alcohol use disorder

Study finds combination therapy to be safe, effective for treatment of male infertility

Experimental drug shows potential to improve bladder function after spinal cord injury

FDA approves first Neulasta biosimilar to help decrease infection risk during cancer treatment

Diuretic drug may be just as effective as oral antibiotics to treat acne in female patients

ORNL increases production of actinium-227 to meet demand for cancer drug

Mistaken belief that antibiotics are harmless is widespread, finds study

Study: People taking immunosuppressant drugs less likely to develop Parkinson's disease

New system for anti-cancer drug delivery offers hope to treat pediatric tumors

Cloud Pharmaceuticals enters into drug discovery collaboration with GSK

FDA approves first oral medication for adults with moderately to severely active ulcerative colitis

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Latest News